Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement

Research output: Contribution to journalArticle

American College of Cardiology and the Society for Cardiovascular Angiography and Interventions, Pinak B. Shah, Frederick G.P. Welt, Ehtisham Mahmud, Alistair Phillips, Neal S. Kleiman, Neal Kleiman, Matthew Sherwood, Wayne Batchelor, Dee Dee Wang, Laura Davidson, Janet Wyman, Sabeeda Kadavath, Molly Szerlip, James Hermiller, David Fullerton, Saif Anwaruddin

The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.

Original languageEnglish (US)
Pages (from-to)1484-1488
Number of pages5
JournalJACC: Cardiovascular Interventions
Volume13
Issue number12
DOIs
StatePublished - Jun 22 2020

PMID: 32250751

Altmetrics

Cite this

Standard

Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic : An ACC/SCAI Position Statement. / American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.

In: JACC: Cardiovascular Interventions, Vol. 13, No. 12, 22.06.2020, p. 1484-1488.

Research output: Contribution to journalArticle

Harvard

American College of Cardiology and the Society for Cardiovascular Angiography and Interventions 2020, 'Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement' JACC: Cardiovascular Interventions, vol. 13, no. 12, pp. 1484-1488. https://doi.org/10.1016/j.jcin.2020.04.001

APA

American College of Cardiology and the Society for Cardiovascular Angiography and Interventions (2020). Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC: Cardiovascular Interventions, 13(12), 1484-1488. https://doi.org/10.1016/j.jcin.2020.04.001

Vancouver

American College of Cardiology and the Society for Cardiovascular Angiography and Interventions. Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC: Cardiovascular Interventions. 2020 Jun 22;13(12):1484-1488. https://doi.org/10.1016/j.jcin.2020.04.001

Author

American College of Cardiology and the Society for Cardiovascular Angiography and Interventions. / Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic : An ACC/SCAI Position Statement. In: JACC: Cardiovascular Interventions. 2020 ; Vol. 13, No. 12. pp. 1484-1488.

BibTeX

@article{ef068e74f9774292baaf47b67160ce3d,
title = "Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement",
abstract = "The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.",
keywords = "COVID-19, MitraClip, TAVR, structural heart disease",
author = "{American College of Cardiology and the Society for Cardiovascular Angiography and Interventions} and Shah, {Pinak B.} and Welt, {Frederick G.P.} and Ehtisham Mahmud and Alistair Phillips and Kleiman, {Neal S.} and Neal Kleiman and Matthew Sherwood and Wayne Batchelor and Wang, {Dee Dee} and Laura Davidson and Janet Wyman and Sabeeda Kadavath and Molly Szerlip and James Hermiller and David Fullerton and Saif Anwaruddin",
year = "2020",
month = "6",
day = "22",
doi = "10.1016/j.jcin.2020.04.001",
language = "English (US)",
volume = "13",
pages = "1484--1488",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier",
number = "12",

}

RIS

TY - JOUR

T1 - Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic

T2 - JACC: Cardiovascular Interventions

AU - American College of Cardiology and the Society for Cardiovascular Angiography and Interventions

AU - Shah, Pinak B.

AU - Welt, Frederick G.P.

AU - Mahmud, Ehtisham

AU - Phillips, Alistair

AU - Kleiman, Neal S.

AU - Kleiman, Neal

AU - Sherwood, Matthew

AU - Batchelor, Wayne

AU - Wang, Dee Dee

AU - Davidson, Laura

AU - Wyman, Janet

AU - Kadavath, Sabeeda

AU - Szerlip, Molly

AU - Hermiller, James

AU - Fullerton, David

AU - Anwaruddin, Saif

PY - 2020/6/22

Y1 - 2020/6/22

N2 - The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.

AB - The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.

KW - COVID-19

KW - MitraClip

KW - TAVR

KW - structural heart disease

UR - http://www.scopus.com/inward/record.url?scp=85083246774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083246774&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2020.04.001

DO - 10.1016/j.jcin.2020.04.001

M3 - Article

VL - 13

SP - 1484

EP - 1488

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

SN - 1936-8798

IS - 12

ER -

Similar Research Outputs

  1. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement

    Shah, P. B., Welt, F. G. P., Mahmud, E., Phillips, A., Kleiman, N., Young, M. N., Sherwood, M., Batchelor, W., Wang, D. D., Davidson, L., Wyman, J., Kadavath, S., Szerlip, M., Hermiller, J., Fullerton, D. & Anwaruddin, S., Jan 1 2020, In : Catheterization and Cardiovascular Interventions.

    Research output: Contribution to journalArticle

ID: 62016010